Current status and future perspective for immunotherapy in head and neck cancer patients
Okamoto, Y.
Nihon Jibiinkoka Gakkai Kaiho 116(2): 118-119
2013
ISSN/ISBN: 0030-6622 PMID: 24163852 Accession: 052412526
PDF emailed within 1 workday: $29.90
Related References
Cabezas-Camarero, S.; Pérez-Segura, P. 2022: Neoadjuvant immunotherapy in head and neck cancer: Rationale, current evidence and future perspective Critical Reviews in Oncology/Hematology 169: 103569Moya-Garcia, C.R.; Okuyama, H.; Sadeghi, N.; Li, J.; Tabrizian, M.; Li-Jessen, N.Y.K. 2022: In vitro models for head and neck cancer: Current status and future perspective Frontiers in Oncology 12: 960340
Rapidis, A.D.; Wolf, G.T. 2009: Immunotherapy of head and neck cancer: current and future considerations Journal of Oncology 2009: 346345
Agada, F.O.; Alhamarneh, O.; Stafford, N.D.; Greenman, J. 2009: Immunotherapy in head and neck cancer: current practice and future possibilities Journal of Laryngology and Otology 123(1): 19-28
Kamio, T. 2013: Current status and future perspective of cancer immunotherapy Nihon Geka Gakkai Zasshi 114(5): 261
Rothschild, U.; Muller, L.; Lechner, A.; Schlösser, H.A.; Beutner, D.; Läubli, H.; Zippelius, A.; Rothschild, S.I. 2018: Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions Swiss Medical Weekly 148: W14625
Aruga, A. 2013: Current status and future perspective of cancer immunotherapy--clinical application and development Nihon Geka Gakkai Zasshi 114(6): 327-331
Nishiyama, M. 2004: Current status and future prospect of therapy for head and neck cancer--future chemotherapy in view of genomic pharmacology Nihon Jibiinkoka Gakkai Kaiho 107(12): 1027-1032
Economopoulou, P.; Kotsantis, I.; Psyrri, A. 2022: Radiotherapy and immunotherapy combination in head and neck cancer: Does current failure qualify as an ending or is it a key to future success? Oral Oncology 125: 105717
Kodaira, T. 2018: III. Current Status and Perspective of Radiation Therapy for Head and Neck Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(7): 1052-1055
Yamaguchi, Y. 2013: Current status and future perspective of cancer immunotherapy--basic understanding of tumor immunology Nihon Geka Gakkai Zasshi 114(5): 262-267
Yabuno, A.; Hasegawa, K. 2020: Ⅲ.The Current Status and Future Perspective of Chemotherapy, Targeted Therapy and Immunotherapy for Cervical Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 47(2): 242-246
Jain, S.; Khuri, F.R.; Shin, D.M. 2004: Prevention of head and neck cancer: current status and future prospects Current Problems in Cancer 28(5): 265-286
Klass, C.M.; Shin, D.M. 2007: Current status and future perspectives of chemoprevention in head and neck cancer Current Cancer Drug Targets 7(7): 623-632
Won, H.-R.; Koo, B.S. 2021: Can we Conquer Advanced Head and Neck Cancer? Current Status and Future Directions Clinical and Experimental Otorhinolaryngology 14(2): 145-146
Dietz, A.; Meyer, A.; Singer, S. 2009: Measuring quality of life in head and neck cancer. Current status and future needs Hno 57(9): 857-865
Argiris, A. 2013: Current status and future directions in induction chemotherapy for head and neck cancer Critical Reviews in Oncology/Hematology 88(1): 57-74
Endo, K.; Yoshizaki, T. 2018: V. Supportive Management in Head and Neck Cancer - Current Status and Future Perspectives Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(7): 1061-1064
Ran, X.; Yang, K. 2017: Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives Drug Design Development and Therapy 11: 2007-2014
Mizuno, T.; Katsuya, Y.; Sato, J.; Koyama, T.; Shimizu, T.; Yamamoto, N. 2022: Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China Frontiers in Oncology 12: 925938